top of page

Mwandishi

Mhariri:

Imeboreshwa:

ULY CLINIC

ULY CLINIC

19 Februari 2026, 15:18:39

Image-empty-state.png
Image-empty-state.png
Image-empty-state.png
Image-empty-state.png

Vitamin B6/Pyridoxine Deficiency

Vitamin B6 (pyridoxine) deficiency is a nutritional disorder caused by inadequate levels of pyridoxine or its active metabolite pyridoxal-5-phosphate (PLP) — an essential coenzyme in amino-acid metabolism, neurotransmitter synthesis, hemoglobin formation, and immune function.

Deficiency primarily affects tissues with high metabolic demand such as:

  • Peripheral nerves

  • Skin

  • Brain

  • Bone marrow

Clinically, it commonly presents with neurological and hematological manifestations, especially peripheral neuropathy and sideroblastic anemia.


2. Physiology and Pathophysiology


Normal Functions of Vitamin B6

Pyridoxine acts as a cofactor in:

System

Function

Nervous system

Synthesis of serotonin, dopamine, GABA

Hematologic

Heme synthesis

Metabolic

Amino acid metabolism & gluconeogenesis

Immune

Lymphocyte proliferation

Skin

Keratin formation


Mechanism of Disease

Deficiency leads to:

  1. ↓ Neurotransmitter synthesis → neuropathy, seizures

  2. ↓ Heme synthesis → sideroblastic anemia

  3. ↑ Homocysteine → vascular risk

  4. Impaired tryptophan metabolism → dermatitis & glossitis

Isoniazid toxicity mechanism:Isoniazid binds pyridoxine → inactive hydrazone complex → functional deficiency.


3. Risk Factors


Nutritional

  • Severe malnutrition

  • Elderly with poor diet

  • Chronic illness

  • Pregnancy

  • Exclusive polished-rice diets


Drug-Induced

  • Isoniazid (most common cause worldwide)

  • Penicillamine

  • Cycloserine

  • Oral contraceptives

  • Levodopa without carbidopa


Disease-Associated

  • Chronic alcoholism

  • Chronic kidney disease

  • HIV infection

  • Malabsorption syndromes

  • Post-bariatric surgery


4. Clinical Features


Early Symptoms

  • Irritability

  • Fatigue

  • Cheilosis

  • Glossitis

  • Seborrheic dermatitis


Neurological Manifestations

  • Tingling sensation

  • Burning pain in feet

  • Numbness

  • Peripheral neuropathy

  • Seizures (infants)

  • Depression

  • Confusion


Hematological Manifestations

  • Microcytic sideroblastic anemia

  • Pallor

  • Weakness


Dermatological Manifestations

  • Angular stomatitis

  • Glossitis

  • Dermatitis (seborrheic type)


Severe Deficiency

  • Encephalopathy

  • Optic neuropathy

  • Ataxia


5. Diagnostic Criteria

Diagnosis is based on clinical suspicion + laboratory confirmation.

Suggestive when patient has:

  • Peripheral neuropathy AND

  • Risk factor (especially TB therapy) AND

  • Response to pyridoxine treatment


6. Investigations


Laboratory Tests

Test

Expected Finding

Plasma pyridoxal-5-phosphate

Low (<20 nmol/L)

CBC

Microcytic or sideroblastic anemia

Homocysteine

Elevated

Iron studies

High ferritin

Bone marrow

Ring sideroblasts (rarely needed)


Differential Diagnoses

  • Vitamin B12 deficiency

  • Diabetic neuropathy

  • Alcoholic neuropathy

  • Hypothyroidism

  • Heavy metal poisoning


7. Management


A. Non-Pharmacological


Lifestyle

  • Stop alcohol use

  • Nutritional rehabilitation

  • Manage malabsorption disorders


Dietary Advice

Increase intake of pyridoxine-rich foods:

  • Liver, meat, fish and offal

  • Wholegrain cereals and fortified breakfast cereals

  • Peanuts and bananas

  • Raw vegetables

  • Walnuts and seeds

  • Avocados and dried fruits

  • Potatoes and baked beans


B. Pharmacological Treatment

i. Treatment of Deficiency

Children

  • Pyridoxine 12.5 mg PO daily × 3 weeks

Adults

  • Pyridoxine 25 mg PO daily × 3 weeks


ii. Drug-Induced Neuropathy (e.g., Isoniazid)

Children

  • Pyridoxine 50 mg PO daily × 3 weeks

Adults

  • Pyridoxine 200 mg PO daily × 3 weeks


iii. Maintenance (for TB therapy)

  • Pyridoxine 25 mg PO daily


4. Acute Neurotoxicity or Seizures (Emergency)

  • Pyridoxine IV 50–100 mg immediately(especially in INH overdose)


8. Monitoring and Follow-Up

Parameter

Frequency

Neuropathy symptoms

Weekly

Hemoglobin

Monthly

TB patients

At each visit

Nutritional status

Monthly

Improvement usually begins within 1–2 weeks, but neuropathy may take months to recover.


9. Complications if Untreated

  • Permanent neuropathy

  • Chronic pain syndrome

  • Seizure disorder in infants

  • Severe anemia

  • Cognitive impairment


10. Prevention


High-Risk Groups (MUST receive prophylaxis)

  • All TB patients on isoniazid

  • Alcohol use disorder

  • Malnourished patients

  • HIV patients

  • Pregnant women on TB therapy


Recommended prophylaxis dose

  • Pyridoxine 10–25 mg daily


11. Prognosis

  • Excellent if treated early

  • Neuropathy reversible in early stages

  • Late treatment → permanent nerve damage


References

  1. World Health Organization. Guideline: vitamin and mineral requirements in human nutrition. 2nd ed. Geneva: WHO; 2004.

  2. National Institutes of Health Office of Dietary Supplements. Vitamin B6 fact sheet for health professionals. Bethesda: NIH; 2023.

  3. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12. Washington DC: National Academy Press; 1998.

  4. Langan RC, Zawistoski KJ. Update on vitamin B6 deficiency. Am Fam Physician. 2011;83(10):1195-9.

  5. O’Leary F, Samman S. Vitamin B6 in health and disease. Nutrients. 2010;2(8):859-71.

  6. StatPearls Publishing. Pyridoxine deficiency. Treasure Island (FL): StatPearls; 2024.

  7. Centers for Disease Control and Prevention. Treatment of tuberculosis: guidelines. Atlanta: CDC; 2022.

  8. British National Formulary (BNF). Pyridoxine hydrochloride monograph. London: BMJ Group and Pharmaceutical Press; 2024.

  9. Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Anastasi J, Weitz J. Hematology: basic principles and practice. 7th ed. Philadelphia: Elsevier; 2018.

  10. Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA. Harper’s illustrated biochemistry. 32nd ed. New York: McGraw-Hill; 2021.


Imeandikwa:

20 Novemba 2020, 11:21:01

bottom of page